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Theophylline in rats during maintenance phase of post.ischemic acute
renal failure. We have shown previously that theophylline increases
both renal plasma flow (RPF) and glomerular filtration rate (GFR)
during the initiation phase of post-ischemic acute renal failure (ARF) in
rats, The purpose of the present experiments was to determine the
effects of theophylline during the maintenance phase of ARF, five days
after initiation. Clearance techniques were used to measure renal
function in a control group of pentobarbital anesthetized rats (group C)
and in three experimental groups, five days after subjecting the left
kidney to a thirty-minute period of complete ischemia. Group SS
received saline during both the ischemic episode and the clearance
measurements; group ST received saline during ischemia and theophyl-
line, acutely, during the clearance measurements; group TS received
theophylline during ischemia and saline during the clearance measure-
ments. In comparison with the values for the control group (group C),
RPF and GFR of the post-ischemic left kidneys of group SS were
approximately half normal. In groups ST and TS, RPF and GFR of the
left kidneys were higher than in group SS. Collectively, these results
demonstrate that pretreatment with theophylline during the initiation
phase of ischemia-induced ARF leads to increased RPF and GFR
during the maintenance phase, and that acute theophylline treatment
during the maintenance phase acutely increases RPF and GFR. Since
increases in GFR were associated with increases in RPF, and since
theophylline is an adenosine receptor antagonist, these results are
consistent with the hypothesis that adenosine-mediated hemodynamic
changes play a pathogenic role in ischemia-induced ARF in rats.
A higher incidence of nonoliguric acute renal failure (ARF)
has been noted during the last decade, due primarily to ad-
vances in management of ARF. In contrast with oliguric ARF,
nonoliguric ARF has fewer complications and a lower mortality
rate, and the duration of azotemia is shorter [1]. Both forms of
ARF, however, are believed to share the same pathophysiolog-
ical mechanisms [2]. These incude hemodynamic changes,
tubular obstruction, and backleak of glomerular filtrate [3].
Increased renovascular resistance and a reduction in renal
blood flow (RBF) accompanied by a reduction in glomerular
filtration rate (GFR), despite a normal arterial blood pressure,
are constant findings in post-ischemic ARF [3—7j. The mediator
of the increased renal vascular resistance and its pathophys-
iological significance with respect to the decreased GFR are still
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debated, although numerous experimental and clinical studies
suggest a hemodynamic basis for the reduction in GFR [7].
We have proposed that increased extracellular adenosine,
produced as a consequence of the energy-deficit state of ARF,
is the mediator [8]. Several previous observations of others
support this proposal (Discussion). Moreover, theophylline is a
competitive, adenosine receptor antagonist [91, and we have
shown that pretreating rats with theophylline had beneficial
effects during the initiation phase of ARF induced by either
thirty or forty-five minutes of complete renal ischemia [10]; the
theophylline-induced increases in GFR of the post-ischemic
kidneys were accompanied by increased renal plasma flow
(RPF), consistent with the hypothesis that adenosine mediates,
at least in part, the hemodynamic changes during the initiation
phase of post-ischemic ARF in rats, and that these changes
account, at least in part, for the reduced GFR. The purpose of
the present studies was to determine the effects of theophylline
during the maintenance phase.
Methods
Adult male Sprague-Dawley rats, weighing between 185 and
314 grams at the time of the clearance experiments, were used
in these studies. The animals were housed in a constant
temperature room with twelve-hour light and dark cycles. They
had free access to tap water and Purina Rodent Chow (Ralston
Purina Co., St. Louis, Missouri, USA). During all aspects of the
experiments, the rats were cared for and used in accordance
with the principles of the Guide for the Care and Use of
Laboratory Animals (DHEW Publication no. NIH 80-23).
Five days before the clearance measurements, the experi-
mental rats were anesthetized with Na pentobarbital (45 mg/kg
administered via a tail vein), and a continuous i.v. infusion
either of saline (groups SS and ST) or of theophylline (111
mol/kg bolus followed by 1.1 pmol/min/kg) in saline (group
TS) was begun via the tail vein, at 0.055 mllmin. A midline
abdominal incision was made to expose the vessels of the left
kidney. The artery was carefully separated from the vein in
order to avoid damaging the nerve plexus. Heparin (250 U/kg)
was injected i.v., and three minutes later the left renal artery
was occluded with a smooth surfaced miniclamp for thirty
minutes, without interfering with the vein. Only those kidneys
that exhibited an immediate paling of the complete surface were
included in the experiments. After removing the arterial clamp,
the incision was closed with sutures, and forty-five minutes
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Table 1. Body weight (BW, grams), plasma Na and K concentrations
(mM), and blood pressure (BP, mm Hg) during the clearance studies
in rats.
Group N BW Na K BP
C 10 270 10 144 1 4.1 0.1 128 3
SS 11 244±8 142±1 3.5±0.1 118±2
ST 12 230 7 140 1 2.9 0.la 108 4
TS 9 251±8 142±1 3.7±0.1 118±3
Means SEMs. C, the control group; the experimental groups
received saline (SS and ST) or theophylline (TS) during the period of
renal ischemia and saline (SS and TS) or theophylline (ST) during the
clearance measurements five days later.
a P < 0.05 compared with all other groups
later, the i.v. infusion was discontinued. The animals were
allowed to recover in their cages, where they had free access to
food and water.
Renal function was measured by clearance techniques in
control rats (group C) and in the three experimental groups
(groups SS, ST, and TS) five days later. Rats were anesthetized
with Na pentobarbital (45 mg/kg body wt, administered via a tail
vein). Supplemental injections were given as required to main-
tain a surgical plane of anesthesia during the experiments. A
tracheotomy was performed, and the left femoral artery and
vein were cannulated with polyethylene tubing. The arterial
cannula was connected to a pressure transducer, and blood
pressure was monitored continuously except during blood
sampling. All rats received an i.v. priming injection of inulin
and para-aminohippurate (2 mi/kg body wt of 10 grams % inulin
and 0.4 grams % para-aminohippurate [PAHI in 150 mM NaCl)
followed by a continuous i.v. infusion at 0.055 ml/min (1.8
grams % inulin and 0.145 grams % PAH in 150 mr'i NaCI).
Theophylline was dissolved in the prime and infusion given to
group ST rats (111 mol/kg prime and 1.1 jimol/min/kg infu-
sion). A midline abdominal incision was made, and the left renal
vein and both ureters were cannulated with polyethylene tubing
as previously described [10]. Seventy-five minutes after begin-
ning the infusion, a forty minute clearance period was begun.
Urine was collected separately from each ureter, and arterial
and renal venous blood samples (about 400 1.d total) were taken
at the clearance midpoint. The blood was centrifuged and
plasma and urine were kept frozen until analyzed as described
below.
Na and K concentrations in plasma and urine were deter-
mined by flame photometry, with internal Li standardization.
Inulin and PAH concentrations in urine and in trichloroacetic
acid filtrates of plasma were determined spectrophotometri-
cally. Standard formulas were used to calculate inulin and PAH
clearances (C1 and CPAH); C1 was taken as the net GFR, the
total filtration rate minus any possible backleak of filtrate. RPF
of the left kidney was calculated as CPAH divided by the PAIl
extraction. Renal functional data were normalized per kg body
weight. All results are expressed as means SEMS. The paired
f-test and ANOVA with Scheffe contrasts were used to assess
the statistical significance of differences within groups (left
versus right kidneys) and between groups, respectively; P
values less than or equal to 0.05 were considered statistically
significant.
Fig. 1. Renal hemodynamic effects of theophylline during the mainte-
nance phase of post-ischemic ARF in rats. Glomerular filtration rate
(GFR), PAH clearance (CPAH), PAH extraction (EpAH) and renal
plasma flow (RPF) were measured in left (open bars) and right kidneys
(crosshatched bars) in control rats (group C, N = 10) and in three
groups of experimental rats five days after a thirty minute period of
ischemia of the left kidney. Group SS (N = 11) was given saline i.v.
during the ischemic period and during the clearance measurements;
group ST (N = 12) was given saline during the ischemia and theophyl-
line during the clearance measurements; group TS (N = 9) was given
theophylline during the ischemia and saline during the clearance mea-
surements. Means saMs; A, P < 0.05 in comparison with the left
kidney of group C; B, P < 0.05 in comparison with the left kidney of
group SS. There were significant differences between the left and right
kidney GFRs in groups SS, ST and TS (P < 0.05 maximum, paired
test) and between the left and right kidney CPAH5 in groups C, SS, and
TS (P < 0.05 maximum, paired t-test).
Results
Means of body weight, plasma Na and K concentrations, and
arterial blood pressure for the four groups of rats are presented
in Table 1. At the time of induction of ARF, body weights were
not significantly different in groups SS, ST and TS: 260 8, 246
6, and 260 8 grams, respectively. In each of these three
groups, body weight decreased significantly (P < 0.05 maxi-
mum, paired f-test) between induction of ARF and the clear-
ance studies. At the time of the clearance studies, body weight
of the control group tended to be higher than body weights of
the three experimental groups (P < 0.05 group C versus SS; P
<0.05 group C versus ST; P> 0.20 group C versus TS). Plasma
Na was nearly the same in all groups, but the acute administra-
tion of theophylline (group ST) lowered plasma K and blood
pressure to values that were significantly different from the
values in all other groups (P < 0.05 maximum, ANOVA).
Clearance data for the four groups of rats are shown in Figure
1. It can be seen that although the PAH extraction of the left
kidney was normal five days post-ischemia (group SS versus
group C), the GFR and the CPAH of the left kidney were
approximately half normal (group SS versus group C, or left
versus right kidneys of group SS). The RPF of the left kidney
was also approximately half normal (group SS versus group C).
The acute administration of theophylline (group ST) had no
effect on the EPAH, but it significantly increased the GFR, the
CPAH, and the RPF of the left kidney (group ST versus group
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Fig. 2. Effects of theophylline during the maintenance phase of post-
ischemic ARF in rats. Urine flow (V), Na excretion (UNaV), nd ratio
of urine to plasma inulin concentrations (U/P1) were measured in left
(open bars) and right kidneys (crosshatched bars) in control rats (group
C, N = 10) and in three groups of experimental rats five days after a
thirty minute period of isehemia 01 the left kidney. Group SS (N 11)
was given saline i.v. during the ischemic period and during the
clearance measurements; group ST (N = 12) was given saline during the
ischemia and theophylline during the clearance measurements; group
TS (N = 9)was given theophylline during the ischemia and saline during
the clearance measurements. Means SEMs.
SS) despite the theophylline-induced reductions in blood pres-
sure in this group (Table 1). In fact, the mean values of GFR,
CPAH, and RPF of the left kidneys in group ST were not
significantly different from the corresponding values in group C.
Theophylline administration during the ischemic period blunted
the ischemia-induced reductions in GFR, CPAH, and RPF with-
out altering EPAH (group TS versus group SS); however, GFR
and RPF of the left kidneys of group TS were still significantly
lower than the corresponding values in the control group (group
C).
Means of urine flow rate (V), Na excretion (UNaV), and ratio
of urine to plasma inulin concentrations (U/P1)are presented in
Figure 2. There were significant differences in these variables
between the left and right kidneys in group C (P < 0.05
maximum, paired t test), despite no differences in GFR and
CPAH (Fig, I), perhaps because of the presence of a catheter in
the left renal vein. These differences limit somewhat the con-
clusions that can be drawn from comparisons of the control
group with the three experimental groups. However, it can be
seen that U/P11, was not suppressed in the post-ischemic left
kidneys of the experimental groups, either in comparison with
the right kidneys of the same animals or in comparison with the
left kidneys of the control group. Moreover, the acute admin-
istration of theophylline led to diuresis and natriuresis in group
ST. In group ST, the total V was 52 5 d/minIkg and the total
UNaV was 11.3 1.5 LM/mm/kg; these values are significantly
(P < 0.05 maximum) greater than the corresponding values in
group SS (39 4 and 6.6 1.5) or in group TS (38 3 and 6.3
0.9). It also appears that theophylline had larger diuretic and
natriuretic effects on the post-ischemic left kidneys than on the
contralateral "control" kidneys in group ST.
Discussion
We have shown previously that a thirty-minute period of
complete renal ischemia produces a nonoliguric form of ARF in
rats [10, 11]. During the initiation phase (thirty minutes after
relieving the arterial occlusion), GFR and CPAH were depressed
to approximately half normal values, and the increased frac-
tional Na excretion and decreased U/P1 were suggestive of
compromised tubular functions [11]. During the maintenance
phase (present study), GFR, CPAH, and RPF were still de-
pressed to approximately half normal values, but the observa-
tion that U/P1 was not decreased suggests some normalization
of tubular functions. Theoretically, the high U/P1, values in the
ARF groups could be attributed to volume depletion, perhaps
resulting from larger urinary fluid losses following the induction
of ARF. The observed weight losses in these groups are
consistent with such an interpretation. However, the normal
hemodynamics of the right kidneys in the experimental groups
argues against any significant volume depletion. Collectively,
our results are qualitatively similar to those obtained by Finn
and Chevalier [5] at two weeks after a 60-minute period of renal
ischemia: despite improvement in morphologic appearance and
several indices of tubular function (normal proximal tubular
fluid pressure, restoration of fractional Na excretion towards
normal, no evidence of inulin backleak), GFR was still mark-
edly reduced.
Hemodynamic factors (increased afferent arteriolar resis-
tance coupled with decreased efferent arteriolar resistance
and/or decreased ultrafiltration coefficient) and tubular factors
(tubular obstruction, backleak of glomerular filtrate) have been
invoked to explain the reduction in GFR. Several observations
argue that not only are hemodynamic factors involved, they
must predominate. First, according to the results of Donohoe et
al [121, tubular factors can account for a 20% reduction in GFR
at most, yet GFR is reduced by more than twice this amount
[10, 11, present results]. Second, RPF is decreased (and there-
fore renovascular resistance is increased) during both the
initiation phase [10, 11] and the maintenance phase (present
results); an increase in afferent arteriolar resistance coupled
with a decrease in efferent arteriolar resistance and/or a de-
crease in the ultrafiltration coefficient can account not only for
the decreased RPF but also for the decreased filtration fraction
and GFR which are commonly observed in post-ischemic and in
other models of ARF [3, 4]. Third, independently of its putative
mechanism of action, theophylline simultaneously increased
RPF and GFR during both the initiation phase [101 and the
maintenance phase (present results) of post-ischemic ARF.
Fourth, independently of its putative mechanism of action,
dipyridamole potentiated the reductions in GFR and CPAH
observed during the initiation phase, and theophylline blocked
these effects and simultaneously increased the RPF [11]. There-
fore, hemodynamic changes account, at least partially, for the
reduced GFR during both the initiation and the maintenance
phases of post-ischemic ARF in rats.
The mediator of the hemodynamic changes is not known, but
on theoretical grounds, it could be increased extracellular
adenosine, produced as a consequence of the energy-deficit
state of ARF [81. First, both endogenously-released and exog-
enous adenosine elicit changes in renovascular resistance
[13—18] that mimic those observed in ARF [191: RPF (or RBF)
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is decreased, at least transiently, and GFR and filtration frac-
tion are decreased even if RPF is increased. Adenosine [131 and
adenosine analogs that act as adenosine receptor agonists [20,
21] constrict afferent and dilate efferent arterioles; depending
upon the relative magnitude of these resistance changes, GFR is
consistently reduced but RPF may decrease, remain constant,
or even increase. Second, kidneys produce and release adeno-
sine into extrscellular fluid during the basal state [22], and
ischemia increases adenosine production and release [22, 23].
In fact, the net loss of adenine nucleotides during ischemia [24,
25] and the accumulation of adenosine and hypoxanthine [22,
23] are all directly related to the duration of ischemia. Although
reperfusion would be expected to remove, or to reduce the
concentration of, any extracellular adenosine that accumulated
during the ischemic episode, adenosine production and release
probably remain elevated during the maintenance phase of
ARF, since adenine nucleotides are depressed throughout the
maintenance phase [25] and since decreased ATP disinhibits
5'-nucleotidase [26], the enzyme that controls adenosine pro-
duction.
Apart from these theoretical considerations, there is pharma-
cological evidence to support the hypothesis that adenosine-
mediated renovascular changes account, at least partially, for
the reduced GFR in several models of ARF. Theophylline is a
competitive adenosine receptor antagonist [9], and we have
shown that it reduces the severity and the duration of glycerol-
induced ARF in rats [27], independently of any diuretic effects
[28]. Bowmers. Collis and Yates [29] have confirmed our
results, using 8-phenyltheophylline, a more potent adenosine
receptor antagonist devoid of phosphodiesterase inhibitory
effects. During the initiation phase of endotoxin-induced ARF
in rats, the administration of theophylline (either concurrently
with or immediately after the endotoxin administration) re-
stores GFR and CPAH towards normal [30]. Also during the
initiation phase of post-ischemic ARF in rats, theophylline
increases both GFR and RPF [10]. Finally, dipyridamole blocks
cellular adenosine uptake, thereby increasing the concentration
nd potentiating the effect of extracellular adenosine [31], and
we have shown that dipyridamole potentiates the reductions in
GFR and CPAH during the initiation phase of post-ischemic ARF
in rats; theophylline reversed these effects of dipyridamole,
simultaneously increasing GFR and RPF [11].
The results of the present study extend the previous obser-
vations cited above, and strengthen the evidence that adeno-
sine-mediated hemodynamic changes are involved in the re-
duced GFR in post-ischemic ARF. Theophylline given during
the initiation phase resulted in increased GFR and RPF not only
during the initiation phase per se [10] but also five days later,
during the maintenance phase. Moreover, theophylline given
during the maintenance phase increased GFR, CPAH, and RPF
to values that were not significantly different from control; in
view of the impaired autoregulation described in this model
[32], these increases were all the more remarkable in that they
occurred despite a significant decrease in arterial blood pres-
sure. Although other vasoactive substances have been shown to
increase the RPF of post-ischemic kidneys, they fail to increase
the GFR significantly [3, 4]. Clearly, theophylline was not
acting as a nonspecific renal vasodilator in our experiments,
since it affected hemodynamics only in the post-ischemic left
kidneys, not in the contralateral kidneys.
In conclusion. theophylline given during the initiation phase
of post-ischemic ARF improves GFR and RPF during both the
initiation and maintenance phases; theophylline given during
the maintenance phase also improves GFR and RPF. Although
theophylline is a phosphodiesterase inhibitor, near m concen-
trations are required [33], and plasma concentrations above 0.1
m are toxic and frequently lethal [34]. In contrast, in the sM
range theophylline acts as a competitive antagonist of adeno-
sine receptors [9]. These considerations strongly suggest that
the mechanism of action of theophylline in vivo is antagonism
of the effect of endogenously-released adenosine [351. There-
fore, the previous [10, Il] and present results suggest that
adenosine-mediated hemodynamic changes play a pathogenic
role in this experimental model of ARF.
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